Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma
Sign Up to like & getrecommendations! Published in 2022 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2022.100930
Abstract: Highlights • 5-year survival for stage I uterine carcinosarcoma without adjuvant therapy is 43%.• Nationally 40% of stage I uterine carcinosarcoma do not receive adjuvant therapy.• Adjuvant chemotherapy alone improved OS and CSS in stage… read more here.
Keywords: survival; adjuvant treatment; uterine carcinosarcoma; stage uterine ... See more keywords
Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes.
Sign Up to like & getrecommendations! Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.07.122
Abstract: OBJECTIVE To assess recent trends of administering adjuvant gemcitabine-docetaxel (GD) chemotherapy for Stage I uterine leiomyosarcoma, and to compare disease-free and overall survival between women who received and did not receive adjuvant GD chemotherapy. METHODS… read more here.
Keywords: chemotherapy; uterine leiomyosarcoma; stage uterine; adjuvant chemotherapy ... See more keywords
Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers.
Sign Up to like & getrecommendations! Published in 2019 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2019.10.017
Abstract: OBJECTIVE Determine the utility of a clinical calculator to predict the benefit of chemotherapy in stage IA uterine papillary serous cancer (UPSC). PATIENTS AND METHODS Data were collected from NCDB from years 2010-2014. Based on… read more here.
Keywords: chemotherapy; clinical calculator; calculator; stage uterine ... See more keywords
Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.
Sign Up to like & getrecommendations! Published in 2019 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2019.12.008
Abstract: OBJECTIVES Determine the impact of adjuvant chemotherapy (ACT) and prognostic factors in surgically managed patients with stage I uterine leiomyosarcoma (ULMS). METHODS Women who underwent hysterectomy and were diagnosed with stage I ULMS between 2010… read more here.
Keywords: prognostic factors; act act; act; stage uterine ... See more keywords
Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2021.12.005
Abstract: OBJECTIVE Utilization of neoadjuvant chemotherapy (NACT) for advanced stage uterine cancer is increasing. We analyzed the use and outcomes of open versus minimally invasive surgery (MIS) for women with stage IV uterine cancer who received… read more here.
Keywords: cancer; surgery; neoadjuvant chemotherapy; stage uterine ... See more keywords
Proposing the 3-tier staging system for improving prognostication in stage I uterine leiomyosarcoma
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic Oncology"
DOI: 10.1016/s0090-8258(21)01121-5
Abstract: Objectives: Current cancer staging uses a 2-tier schema for stage I uterine leiomyosarcoma based on tumor size (≤5cm versus >5cm). Given the majority of stage I uterine leiomyosarcomas are >5cm in tumor size, this study… read more here.
Keywords: stage uterine; size; tumor size; uterine leiomyosarcoma ... See more keywords
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Gynecologic Oncology"
DOI: 10.3802/jgo.2017.28.e46
Abstract: Objective To evaluate the oncologic safety of ovarian preservation (OP) in premenopausal women diagnosed with the International Federation of Gynecology and Obstetrics (FIGO) stage I uterine sarcoma. Methods The National Cancer Institute's Surveillance, Epidemiology, and… read more here.
Keywords: sarcoma; premenopausal women; preservation premenopausal; ovarian preservation ... See more keywords